Search

Issue
Title
Authors
Search for predictors of psoriatic arthritis in patients with psoriasis
Artamonova O.G., Karamova A.E., Kubanov A.A., Verbenko D.A., Kozlova I.V.
The role of cells of the innate immune system in psoriasis
Sorokina E.V., Bisheva I.V.
Experience of using ustekinumab in the treatment of a patient with HIV-associated psoriasis and anogenital warts
Babkova M.I., Arshinsky M.I., Frolova Z.V., Chudina O.A., Mitrofanova J.S., Batalova S.K.
Periods till psoriatic arthritis onset and diagnosis in Russian patients with moderate to severe psoriasis (according to psoriasis patient registry)
Kubanov A.A., Bogdanova E.V.
Resources and performance rates of medical organizations providing medical care in the field of dermatovenereology in the Russian Federation in 2016–2022
Kubanov A.A., Bogdanova E.V.
Langerhans cells and gamma delta Т-lymphocytes in the pathogenesis of psoriasis
Sorokina E.V., Kalinichenko E.O., Bisheva I.V., Stolpnikova V.N.
Psoriatic erythroderma: comparative patient profile and association with psoriatic arthritis
Bogdanova E.V.
Revisiting the question of psoriasis classification
Karamova A.E., Olisova O.Y., Bakulev A.L., Kokhan M.M., Khairutdinov V.R., Sokolovskiy E.V., Khobeych M.M.
A prospective open-label study of the antifungal activity of external forms of activated zinc pyrithione in the treatment of Malassezia-associated skin diseases
Samtsov A.V., Patrushev A.V., Chepushtanova K.O., Bogdanova T.V., Alekssev A.Y., Bogomolova T.S., Vasilyeva N.V.
Anticytokine therapy with interleukin-17 in patients with moderate and severe psoriasis
Kovaleva J.S., Kazantsev I.V., Aibazova A.A., Ovchinnikova E.O., Garina A.A., Shabaldina A.P.
Epidemiology of psoriasis in the Russian Federation according to the patient registry
Kubanov A.A., Bogdanova E.V.
Efficacy and safety of netakimab therapy in patients with moderate to severe psoriasis in real clinical practice
Bakulev A.L., Pritulo O.A., Kuntsevich Z.S., Khotko A.A., Yunovidova A.A., Gorognichev P.V., Ziganshin O.R., Rudneva N.S., Bildyuk E.V., Repina T.V., Dudko V.Y., Maksimova M.D.
Predictive model and classification for psoriatic arthritis risk assessment for Russian patients with psoriasis (on registry data)
Bogdanova E.V.
Efficacy and safety of treatment of moderate and severe psoriasis with the interleukin 23 inhibitor risankizumab
Bakulev A.L., Kruglova L.S.
The peripheral blood regulatory T-cells analysis as a criterion for assessing the therapy efficacy and a prognostic marker for the duration of remission of psoriasis
Olisova O.Y., Gudova V.V.
Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/PLANETA clinical trial
Bakulev A.I., Samtsov A.V., Sokolovskiy E.V., Kokhan M.M., Khobeish M.M., Khairutdinov V.R., Karamova A.E., Olisova O.U., Ignatiev D.V., Nikiforova A.N., Artemeva A.V., Zinkina-Orikhan A.V.
Influence of ABCB1 3435C>T polymorphism on methotrexate safety in patients with psoriasis
Kubanov A.A., Asoskova A.V., Zastrozhin M.S., Sozaeva Z.A., Sychev D.A.
Disorders of the skin microbiome in atopic dermatitis and psoriasis
Nikolaeva M.Y., Monakhov K.N., Sokolovskiy E.V.
Guselkumab in the treatment of patients with plaque psoriasis of moderate and severe severity: Efficacy and safety of interleukin-23 blockade
Chikin V.V.
The age at first cutaneous manifestation of psoriasis as a prognostic factor in the timing of psoriatic arthritis diagnosis
Bogdanova E.V.
Assessment of CLA+T-cell subpopulations in the blood of patients with chronic dermatoses
Patrushev A.V., Samtsov A.V., Nikitin V.Y., Soukharev A.V., Gumilevskaya O.P., Sukhina I.A.
Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial
Puig L., Bakulev A.L., Kokhan M.M., Samtsov A.V., Khairutdinov V.R., Morozova M.A., Zolkin N.A., Kuryshev I.V., Petrov A.N., Artemeva A.V., Zinkina-Orikhan A.V.
Comprehensive assessment of the dynamics of angiogenesis in patients with psoriasis treated with methotrexate
Pritulo O.A., Petrov A.A.
Precision therapy for psoriasis patients
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Psoriatic onychodystrophy: indices for assessing the severity of psoriatic onychodystrophy (part 2)
Platonova A.V., Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
ENTHESITIS AND PSORIATIC ONYCHOPATHY AS A FACTOR FOR PREDICTION OF PSORIATIC ARTHRITIS IN PSORIASIS
Sidorcika T.G., Linovs V.A., Radzina M.A., Rubins A.J., Rubins S.A.
Evolution of the understanding of psoriasis and therapeutic approaches used to manage such patients. BCD-085 is the first Russian genetically-engineered biological preparation for the treatment of patients suffering from psoriasis
Bakulev A.L.
Targeted therapy of psoriasis: inhibition of the IL-23 signaling pathway — evidence from clinical studies and real practice
Hotko A.A., Pomazanova M.Y., Kruglova L.
Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis
Olisova O.Y., Svistunova D.A., Chernyavskaya L.M., Anpilogova E.M.
Features of treatment of patients with psoriasis with metabolic syndrome
Khairutdinov V.R., Samtsov A.V.
SYSTEM THERAPY OF PSORIASIS IN CHILDREN (PART I)
Namazova-Baranova L.S., Murashkin N.N., Ambarchyan E.T., Materikin A.I.
Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis
Kubanov A.A., Bakulev A.L., Samtsov A.V., Khairutdinov V.R., Sokolovskiy E.V., Kokhan M.M., Artemyeva A.V., Chernyaeva E.V., Ivanov R.A.
Psoriasis: clinical and epidemiological features and therapy issues
Bakulev A.L., Fitileva T.V., Novodezerkina E.А., Gilloteau I., Tian Н., Howe T., Pietri G.
ASSOCIATED PATHOLOGY: CLINICAL ОBSERVATION
Tlish M.M., Popovskayа E.B., Sycheva N.L., Sorokina N.V., Psavok F.A.
Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
Kubanov A.A., Bakulev A.L., Gluzmin M.I., Kokhan M.M., Kruglova L.S., Rudneva N.S., Olisova O.Y., Sokolovsky E.V., Khobeish M.M.
Prevalence of chronic infection foci in patients with dermatoses
Patrushev A.V., Samtsov A.V., Ivanov A.M., Sukharev A.V., Asfendiarov D.D.
ACRODERMATITIS CONTINUA SUPPURATIVA HALLOPEAU IN COMBINATION WITH LOCALIZED PSORIASIS VULGARIS
Sokolovskiy E.V., Mikheev G.N.,  Gordeeva A.A.
The new external drug for the treatment of psoriasis based on inhibition of serine proteases
Zhukov A.S., Zharun E.R., Khairutdinov V.R., Samtsov A.V., Krasavin M.Y., Garabagiou A.V.
Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19
Kubanov A.A., Bakulev A.L., Kokhan M.M., Olisova O.Y., Samtsov A.V., Sokolovskiy E.V., Khairutdinov V.R., Khobeish M.M.
Distribution of melanocytes in the skin of psoriasis patients
Zhukov A.S., Khairutdinov V.R., Belousova I.E., Samtsov A.V.
Experience in the treatment of psoriasis patients using Apremilast, a selective signalling pathway inhibitor
Kungurov N.V., Zilberberg N.V., Kokhan M.M., Keniksfest J.V., Grishaeva E.V.
Origin, function and role in the development of skin diseases CLA+T-lymphocytes
Patrushev A.V., Samtsov A.V., Nikitin V.Y., Ivanov A.М., Gumilevskaya O.Р., Sukharev A.V., Sukhina I.A.
Methotrexate: Revisited efficiency and safety of drug administration in psoriasis patients
Bakulev A.L.
Clinical evidence of therapy for genital psoriasis by biologic agents
Sokolovskiy E.V., Kokhan M.M.
Vulgar psoriasis and squamous cell carcinoma in a patient with discoid lupus erythematosus
Dubensky V.V., Nekrasova E.G., Alexandrova O.A., Muraveva E.S.
Results of the long-term observational noninterventional prospective study BODYGUARD in psoriasis patients
Bakulev A.L., Petrunin D.D.
Indices of peroxidation of lipids of biological membranes and endogenous intoxication in patients with psoriasis on the background of chronic viral hepatitis С
Marzhokhova M.Y., Hussein A., Marzhokhova A.R.
Perspective trends of topical therapy of patients with psoriasis
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Comparative study of anti-inflammatory activity of zinc pyrition on a psoriasis laboratory model
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Studying of the interleukin-36γ expression level in the skin of patients with plaque psoriasis
Pashkin A.Y., Zhukov A.S., Khairutdinov V.R., Belousova I.E., Samtsov A.V., Garabagiou A.V.
Psoriatic onychodystrophy: clinical manifestations (part 1)
Platonova A.V., Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Systemic Psoriasis Treatment at an Early Age (Part II): Issues of Biological Therapy
Namazova-Baranova L.S., Murashkin N.N., Ambarchian E.T., Materikin A.I.
Features of the cytokine profile and the effectiveness of radical treatment of focal infection in patients with psoriasis
Patrushev A.V., Samtsov A.V., Soukharev A.V.
The Actual Challenges of Biologics Treatment in Patients with Psoriasis
Bakulev A.L.
Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext
Bakulev A.L., Samtsov A.V., Kubanov A.A., Khairutdinov V.R., Kokhan M.M., Artemyeva A.V., Derbin S.I., Chernyaeva E.V., Ivanov R.A.
Effectiveness of resuming ustekinumab therapy in psoriasis patients with metabolic disorders. Clinical experience
Rychkova I.V., Prytulo O.A.
Efficacy and Safety of BCD-085, a Novel Interleukin-17 Inhibitor. Results of Phase II Clinical Trial in Patients with Moderate-to-Severe Plaque Psoriasis
Samtsov A.V., Khairutdinov V.R., Bakulev A.L., Kubanov A.A., Karamova A.E., Artem’eva A.V., Korotaeva T.V.
Systemic treatment of psoriasis: from methotrexate to biologics
Olisova O.Y., Anpilogova E.M.
Profiles of patients with psoriasis for appointment gene-engineering biological therapy — clinical justification
Zhukov A.S., Khotko A.A., Khairutdinov V.R., Samtsov A.V.
Influence of focal infection on the immune status of psoriasis patients
Patrushev A.V., Samtsov A.V., Nikitin V.Y., Sukharev A.V., Ivanov A.M., Gumilevskaya O.P., Sukhina I.A.
Signaling Рathway Blockers: Action Mechanism, Efficacy, Safety of Therapy for Patients with Psoriasis and Psoriatic Arthritis
Bakulev A.A.
1 - 61 of 61 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies